DHTYX | JVMSX | DHTYX / JVMSX | |
Total Expense Ratio | 0.75 | 1.25 | 60% |
Annual Report Gross Expense Ratio | 0.75 | 1.26 | 60% |
Fund Existence | 13 years | 13 years | - |
Gain YTD | -6.054 | -2.424 | 250% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 543M | 20.6B | 3% |
Annual Yield % from dividends | 0.96 | 0.46 | 210% |
Returns for 1 year | -6.92 | -8.45 | 82% |
Returns for 3 years | 16.86 | 4.66 | 362% |
Returns for 5 years | 87.84 | 50.94 | 172% |
Returns for 10 years | 67.91 | 27.80 | 244% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 78.04 | 0.69 | +0.89% |
SPDR® S&P Biotech ETF | |||
XBAP | 35.08 | 0.15 | +0.44% |
Innovator US Eq Acltd 9 Bfr ETFTM April | |||
MARW | 31.14 | 0.11 | +0.34% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
DFSI | 37.11 | -0.01 | -0.02% |
Dimensional International Sstby Cr 1 ETF | |||
BFIX | 25.14 | -0.08 | -0.30% |
Build Bond Innovation ETF |